BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 4122212)

  • 1. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentration by Diaflo ultrafiltration of murine leukemia and sarcoma viruses grown in tissue cultures.
    Rhim JS; Williams LB; Huebner RJ; Turner HC
    Cancer Res; 1969 Jan; 29(1):154-6. PubMed ID: 4303443
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the biological and antigenic properties of ESP-1 type C virus particles.
    Eckner RJ; Priori ES; Mirand EA; Dmochowski L
    Cancer Res; 1974 Oct; 34(10):2521-9. PubMed ID: 4137948
    [No Abstract]   [Full Text] [Related]  

  • 5. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.
    Aoki T; Stephenson JR; Aaronson SA
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):742-6. PubMed ID: 4351802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 9. Properties of mouse leukemia viruses. II. Isolation of viral components.
    Schäfer W; Lange J; Fischinger PJ; Frank H; Bolognesi DP; Pister L
    Virology; 1972 Jan; 47(1):210-28. PubMed ID: 4110127
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative serological studies on type C viruses of various mammals.
    Schäfer W; Pister L; Hunsmann G; Moennig V
    Nat New Biol; 1973 Sep; 245(142):75-7. PubMed ID: 4125728
    [No Abstract]   [Full Text] [Related]  

  • 11. Rat embryo cells in complement fixation tests for murine leukemia virus.
    Rhim JS; Huebner RJ
    Nature; 1970 May; 226(5246):646-7. PubMed ID: 4315549
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components.
    Schäfer W; Fischinger PJ; Lange J; Pister L
    Virology; 1972 Jan; 47(1):197-209. PubMed ID: 4333567
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the FMR antigen.
    Lilly F; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
    [No Abstract]   [Full Text] [Related]  

  • 15. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses.
    Lee JC; Ihle JN
    J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.
    Steeves RA; Strand M; August JT
    J Virol; 1974 Jul; 14(1):187-9. PubMed ID: 4134470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
    Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
    Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of murine leukemia virus gag antigen with extracellular matrices in productively infected mouse cells.
    Edwards SA; Lin YC; Fan H
    Virology; 1982 Jan; 116(1):306-17. PubMed ID: 6278711
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

  • 20. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
    Hanna MG; Ihle JN; Lee JC
    Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.